US Patent 11472791 Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
Patent 11472791 was granted and assigned to Incyte on October, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+14 properties)
Infobox
Patent Inventor Names
Ding-Quan Qian0
Fenglei Zhang0
Jeffrey C. Yang0
Jingwei Li0
Joshua Hummel0
Kaijiong Xiao0
Liangxing Wu0
Margaret Favata0
Meizhong Xu0
Min Ye0
Wenqing Yao0
Yingnan Chen0
Yvonne Lo0
Zhenwu Li0
Edits on 26 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 21 Apr, 2023
Golden AI
Infobox
Edits on 28 Oct, 2022
Golden AI
Edits made to:
Infobox (+12 properties)
Article (+202 characters)
US Patent 11472791 Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
Article
The present application provides pyrazolyl pyrimidinylamine inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114727910
Date of Patent
October 18, 2022
0Patent Application Number
168092180
Date Filed
March 4, 2020
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11472791 Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
